This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Cefepime and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (116)
Death (15)
Life Threatening Events (20)
Disability (2)
Reports by Reaction Type
Renal Failure Acute (24),
Confusional State (21),
Encephalopathy (19),
Myoclonus (17),
Neurotoxicity (14),
Status Epilepticus (12),
Renal Failure (11),
Diarrhoea (11),
Pyrexia (9),
Febrile Neutropenia (9),
Altered State of Consciousness (9),
Rhabdomyolysis (8)
Below are a few examples of reports where side effects / adverse reactions may be related to Cefepime. For a complete list or a specific selection of reports, please use the links above.
Possible Cefepime side effects in 84 year old male
Reported by a physician from United States on 2012-08-24
Patient: 84 year old male
Reactions: Drug Hypersensitivity, Condition Aggravated, Rash Morbilliform
Drug(s) suspected as cause:
Cefepime
Ceftriaxone
Other drugs received by patient: Piperacillin / Tazobactam; Esomeprazole Sodium; Meropenem
Possible Cefepime side effects in 17 year old male
Reported by a physician from Poland on 2012-08-23
Patient: 17 year old male
Reactions: Rhabdomyolysis, Disseminated Intravascular Coagulation, Pancytopenia, Pyrexia, Renal Failure, Neutropenia, Clostridial Infection, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cefepime
Doxorubicin Hydrochloride
Indication: Ewing's Sarcoma
Etoposide
Indication: Ewing's Sarcoma Metastatic
Ifosfamide
Indication: Ewing's Sarcoma Metastatic
Meropenem
Metronidazole
Netromycin
Vancocin Hydrochloride
Vincristine
Indication: Ewing's Sarcoma Metastatic
Other drugs received by patient: Fluconazole; Caspofungin Acetate
Possible Cefepime side effects in 17 year old male
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient: 17 year old male, weighing 89.9 kg (197.8 pounds)
Reactions: Pharyngeal Inflammation, Hypoxia, Caecitis, Rash Maculo-Papular, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefepime
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-28
Cytarabine
Dosage: unk
Start date: 2012-05-18
End date: 2012-05-18
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-26
Possible Cefepime side effects in 57 year old female
Reported by a pharmacist from United States on 2012-08-22
Patient: 57 year old female, weighing 108.0 kg (237.6 pounds)
Reactions: Multi-Organ Failure, Drug Resistance, Status Epilepticus, Renal Failure Acute
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cefepime
Possible Cefepime side effects in 75 year old male
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-08-20
Patient: 75 year old male, weighing 88.0 kg (193.6 pounds)
Reactions: Myoclonus, Drug Level Increased, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cefepime
Indication: Intervertebral Discitis
Start date: 2012-04-07
End date: 2012-04-21
Citalopram Hydrobromide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-03
Duragesic-100
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-11
End date: 2012-04-19
Lasilactone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-07
Lasix
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-09
End date: 2012-04-16
Lasix
Administration route: Oral
Start date: 2012-03-13
End date: 2012-04-07
Morphine
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-13
Torsemide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-17
Tramadol Hydrochloride
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-13
End date: 2012-03-14
Vancocin Hydrochloride
Indication: Intervertebral Discitis
Start date: 2012-04-07
End date: 2012-04-21
Other drugs received by patient: Metoprolol Tartrate; Moviprep; Dalteparin Sodium; Dalteparin Sodium; Novalgin; Folvite; Marcumar; Acetaminophen; Lyrica; Navoban; Cozaar; Imodium; Perenterol; Ondansetron; Dipiperon; Nitroderm; Motilium; Levothyroxine Sodium; Allopurinol; Konakion; Droperidol; Pantoprazole
Possible Cefepime side effects in 17 year old male
Reported by a consumer/non-health professional from Poland on 2012-08-09
Patient: 17 year old male
Reactions: Rhabdomyolysis, Pancytopenia, Clostridial Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Caspofungin Acetate
Cefepime
Doxorubicin Hydrochloride
Indication: Ewing's Sarcoma Metastatic
Etoposide
Indication: Ewing's Sarcoma Metastatic
Fluconazole
Ifosfamide
Indication: Ewing's Sarcoma Metastatic
Metronidazole
Netromycin
Vincristine
Indication: Ewing's Sarcoma Metastatic
Possible Cefepime side effects in 17 year old male
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-08-02
Patient: 17 year old male
Reactions: Rhabdomyolysis, Pancytopenia, Clostridial Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Caspofungin Acetate
Cefepime
Doxorubicin Hydrochloride
Indication: Ewing's Sarcoma Metastatic
Etoposide
Indication: Ewing's Sarcoma Metastatic
Fluconazole
Ifosfamide
Indication: Ewing's Sarcoma Metastatic
Metronidazole
Netromycin
Vincristine
Indication: Ewing's Sarcoma Metastatic
Possible Cefepime side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient:
Reactions: Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aspirin
Cefepime
Heparin Sodium
Meropenem
Nitro-DUR
Pepcid
Administration route: Oral
Piperacillin and Tazobactam
Vancomycin
Zocor
Administration route: Oral
Possible Cefepime side effects in 33 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: 33 year old male, weighing 93.0 kg (204.6 pounds)
Reactions: Lactobacillus Infection, Blood PH Increased, Tachycardia, Blood PH Decreased, Device Related Infection, Scleral Haemorrhage, Bacterial Sepsis, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Blood Bicarbonate Increased, Acute Respiratory Failure, Renal Failure Acute, Febrile Neutropenia, Haemodialysis, Alopecia, Treatment Failure, Base Excess Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
(Investigational Drug)
Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-17
End date: 2012-04-23
(Investigational Drug)
Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-02
End date: 2012-04-08
Amphotericin B
Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
Indication: Fungal Infection
Start date: 2012-05-06
End date: 2012-05-08
Amphotericin B
Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
Indication: Infection Prophylaxis
Start date: 2012-05-06
End date: 2012-05-08
Aztreonam
Dosage: see image
Indication: Bacterial Infection
Start date: 2012-05-06
End date: 2012-05-07
Aztreonam
Dosage: see image
Indication: Bacterial Infection
Start date: 2012-04-09
End date: 2012-04-10
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-04-09
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-04-08
End date: 2012-04-08
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-05-20
End date: 2012-05-22
Cefepime
Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-03-29
End date: 2012-04-10
Cefepime
Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-06-02
End date: 2012-06-05
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-14
End date: 2012-04-20
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-04-05
Daunorubicin HCL
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-04-01
Daunorubicin HCL
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-14
End date: 2012-04-16
Imipenem and Cilastatin
Dosage: 1000 mg, q8 hours intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-05-07
End date: 2012-05-28
Penicillin G
Dosage: 24000000 u, q24 hrs intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-05-04
End date: 2012-05-09
Vancomycin
Indication: Product Used FOR Unknown Indication
Voriconazole
Dosage: 522 mg, q12 hours, intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-08
End date: 2012-05-08
Other drugs received by patient: Ondansetron; Seroquel; Percocet; Nystatin; Zyloprim; Acetaminophen; Calcium Carbonate; Lorazepam; Xanax; Allopurinol; Calcium Gluconate; Ibuprofen; Hydroxyzine Pamoate; Celexa
Possible Cefepime side effects in 65 year old female
Reported by a physician from India on 2012-07-30
Patient: 65 year old female
Reactions: Myoclonus, Chorea, Aphasia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefepime
Possible Cefepime side effects in 17 year old male
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-07-23
Patient: 17 year old male
Reactions: Abdominal Pain, Rhabdomyolysis, Pain in Extremity, Disseminated Intravascular Coagulation, Chromaturia, Pancytopenia, Pyrexia, Renal Failure, Renal Impairment, Diarrhoea, Clostridial Infection, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cefepime
Indication: Pyrexia
Doxorubicin HCL
Indication: Ewing's Sarcoma Metastatic
Etoposide
Indication: Ewing's Sarcoma Metastatic
Ifosfamide
Indication: Ewing's Sarcoma Metastatic
Netilmicin Sulfate
Indication: Pyrexia
Vincristine
Indication: Ewing's Sarcoma Metastatic
Possible Cefepime side effects in 61 year old female
Reported by a consumer/non-health professional from France on 2012-07-20
Patient: 61 year old female, weighing 120.0 kg (264.0 pounds)
Reactions: Confusional State, Overdose, Status Epilepticus
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cefepime
Other drugs received by patient: Tenormin; Esidrix
Possible Cefepime side effects in 67 year old female
Reported by a consumer/non-health professional from France on 2012-07-11
Patient: 67 year old female
Reactions: Overdose, Rectal Haemorrhage, Hypotension, Pancytopenia, Encephalopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cefepime
Indication: Osteomyelitis
Start date: 2012-06-02
End date: 2012-06-06
Piperacillin
Dosage: intead of 6gm/day ,2mg/day introduced
Indication: Osteomyelitis
Start date: 2012-06-04
End date: 2012-06-07
Other drugs received by patient: Acupan; Levothyroxine Sodium; Folic Acid; Vancomycin; Rabeprazole Sodium; Omeprazole; Oxycodone HCL; Gentamicin
Possible Cefepime side effects in 61 year old female
Reported by a pharmacist from United States on 2012-07-11
Patient: 61 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Dysarthria, Tremor, Dysphemia
Drug(s) suspected as cause:
Cefepime
Other drugs received by patient: Senna-Mint WAF; Oxycodone HCL and Acetaminophen; Potassium Chloride; Oxybutynin; Praastatin; Prochlorperazine; Allergy Relief Capsule
Possible Cefepime side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Musculoskeletal Pain, Hyponatraemia, Pyrexia, Purpura, Hypokalaemia, Hypophosphataemia, Oedema Peripheral, Hypomagnesaemia, Deep Vein Thrombosis, Muscle Spasms
Drug(s) suspected as cause:
Ambisome
Dosage: unk
Indication: Fungal Infection
Start date: 2012-04-28
End date: 2012-04-30
Cefepime
Dosage: unk
Indication: Fungal Infection
End date: 2012-05-03
Other drugs received by patient: Etoposide; Cytarabine; Idarubicin HCL
Possible Cefepime side effects in 14 year old female
Reported by a physician from United States on 2012-07-03
Patient: 14 year old female, weighing 60.4 kg (132.9 pounds)
Reactions: Stomatitis, Hypotension, Encephalopathy, Acidosis, Hypercalcaemia, Respiratory Failure, Sepsis, Posterior Reversible Encephalopathy Syndrome, Hypocalcaemia, Enterocolitis, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ambisome
Dosage: unk
Indication: Candida Test Positive
Start date: 2012-05-20
Calcium Gluconate
Cefepime
Dosage: unk
Indication: Klebsiella Infection
Start date: 2012-05-10
Dexamethasone Sodium Phosphate
Dosage: 10 mg/m2, bid or iv on days 1-5 and 15-19
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Methotrexate Sodium
Dosage: 8-15 mg (age based dosing) it on days 1 (or up to 72 hours prior to day 1) and 8
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Mitoxantrone Hydrochloride
Dosage: 10 mg/m2, over 30 minutes on days 1 and 2
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Pegaspargase
Dosage: 2500 iu/m2 over 1 hr on days 3 and 17
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Temsirolimus
Dosage: 7.5 mg/m2, over 30 minutes on days i, 8 and 15 (max dose: 15 mg)
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Vincristine Sulfate
Dosage: 1.5 mg/m2 cyclic (max 2 mg) over i-5 minutes or infusion via mini bag on days 1, 8, i5 and 22
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Possible Cefepime side effects in 67 year old female
Reported by a physician from France on 2012-06-29
Patient: 67 year old female
Reactions: Overdose, Hypotension, Rectal Haemorrhage, Pancytopenia, Encephalopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cefepime
Indication: Osteomyelitis
Start date: 2012-06-02
End date: 2012-06-06
Piperacillin
Indication: Osteomyelitis
Start date: 2012-06-04
End date: 2012-06-07
Other drugs received by patient: Acupan; Gentamicin; Omeprazole; Oxycodone HCL; Rabeprazole Sodium; Levothyroxine Sodium; Folic Acid; Vancomycin
Possible Cefepime side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: 58 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Skin Lesion, Rash Maculo-Papular
Drug(s) suspected as cause:
Allopurinol
Dosage: 300mg qd po
Administration route: Oral
Indication: Tumour Lysis Syndrome
Start date: 2012-06-21
End date: 2012-06-23
Allopurinol
Dosage: 300mg qd po
Administration route: Oral
Indication: Prophylaxis
Start date: 2012-06-21
End date: 2012-06-23
Cefepime
Dosage: 2g q8h iv
Indication: Evidence Based Treatment
Start date: 2012-06-21
End date: 2012-06-22
Cefepime
Dosage: 2g q8h iv
Indication: Infection
Start date: 2012-06-21
End date: 2012-06-22
Possible Cefepime side effects in 14 year old female
Reported by a physician from United States on 2012-06-28
Patient: 14 year old female, weighing 60.4 kg (132.9 pounds)
Reactions: Stomatitis, Hypotension, Encephalopathy, Acidosis, Hypercalcaemia, Respiratory Failure, Sepsis, Posterior Reversible Encephalopathy Syndrome, Hypocalcaemia, Enterocolitis, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ambisome
Dosage: unk
Indication: Candida Test Positive
Start date: 2012-05-20
Calcium Gluconate
Cefepime
Dosage: unk
Indication: Klebsiella Infection
Start date: 2012-05-10
Dexamethasone Sodium Phosphate
Dosage: 10 mg/m2, bid or iv on days 1-5 and 15-19
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Methotrexate
Dosage: 8-15 mg (age based dosing) it on days 1 (or up to 72 hours prior to day 1) and 8
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Mitoxantrone Hydrochloride
Dosage: 10 mg/m2, over 30 minutes on days 1 and 2
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Pegaspargase
Dosage: 2500 iu/m2 over 1 hr on days 3 and 17
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Temsirolimus
Dosage: 7.5 mg/m2, over 30 minutes on days i, 8 and 15 (max dose: 15 mg)
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Vincristine
Dosage: 1.5 mg/m2 cyclic (max 2 mg) over i-5 minutes or infusion via mini bag on days 1, 8, i5 and 22
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-04-30
Possible Cefepime side effects in 46 year old female
Reported by a pharmacist from United States on 2012-06-19
Patient: 46 year old female, weighing 75.0 kg (165.0 pounds)
Reactions: Vitamin K Deficiency, Drug Resistance, Inhibitory Drug Interaction
Drug(s) suspected as cause:
Cefepime
Indication: Subcutaneous Abscess
Nafcillin
Indication: Endocarditis Staphylococcal
Vancomycin
Indication: Subcutaneous Abscess
Other drugs received by patient possibly interacting with the suspect drug: Infuvite Pediatric
Dosage: 150 microg daily
Indication: Hypophagia
Intralipid / 00272201 /
Dosage: 20% soya oil emulsion (250ml), 132.5 microg vitamin k on mon, wed, fri
Indication: Hypophagia
Warfarin Sodium
Dosage: 1mg daily
Indication: Deep Vein Thrombosis
Other drugs received by patient: Heparin
Possible Cefepime side effects in 46 year old female
Reported by a pharmacist from United States on 2012-06-19
Patient: 46 year old female, weighing 75.0 kg (165.0 pounds)
Reactions: Vitamin K Deficiency, Drug Resistance, Inhibitory Drug Interaction
Drug(s) suspected as cause:
Cefepime
Indication: Subcutaneous Abscess
Nafcillin
Indication: Endocarditis Staphylococcal
Vancomycin
Indication: Subcutaneous Abscess
Other drugs received by patient possibly interacting with the suspect drug: Infuvite Pediatric
Dosage: 150 microg daily
Indication: Hypophagia
Intralipid / 00272201 /
Dosage: 20% soya oil emulsion (250ml), 132.5 microg vitamin k on mon, wed, fri
Indication: Hypophagia
Warfarin Sodium
Dosage: 1mg daily
Indication: Deep Vein Thrombosis
Other drugs received by patient: Heparin
Possible Cefepime side effects in 17 year old male
Reported by a physician from United States on 2012-06-15
Patient: 17 year old male, weighing 89.9 kg (197.8 pounds)
Reactions: Pharyngeal Inflammation, Hypoxia, Caecitis, Rash Maculo-Papular, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefepime
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: unk
Start date: 2012-05-18
End date: 2012-05-18
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-28
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-26
Possible Cefepime side effects in 84 year old
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-14
Patient: 84 year old
Reactions: Neurotoxicity, Overdose, Clonus, Somnolence
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefepime
Possible Cefepime side effects in 49 year old
Reported by a individual with unspecified qualification from France on 2012-06-14
Patient: 49 year old
Reactions: Neurotoxicity, Confusional State, Overdose, Creatinine Renal Clearance Decreased, Drug Level Increased, Somnolence
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefepime
Possible Cefepime side effects in
Reported by a pharmacist from United States on 2012-06-08
Patient:
Reactions: Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aspirin
Indication: Product Used FOR Unknown Indication
Cefepime
Indication: Product Used FOR Unknown Indication
Famotidine
Indication: Product Used FOR Unknown Indication
Famotidine
Heparin
Indication: Product Used FOR Unknown Indication
Meropenem
Indication: Product Used FOR Unknown Indication
Nitroglycerin
Indication: Product Used FOR Unknown Indication
Piperacillin and Tazobactam
Indication: Product Used FOR Unknown Indication
Simvastatin
Indication: Product Used FOR Unknown Indication
Vancomycin
Indication: Product Used FOR Unknown Indication
Possible Cefepime side effects in 91 year old male
Reported by a physician from United States on 2012-06-04
Patient: 91 year old male, weighing 83.9 kg (184.6 pounds)
Reactions: Delirium
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefepime
Possible Cefepime side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31
Patient: 59 year old male
Reactions: Tubulointerstitial Nephritis, Renal Failure, Encephalopathy, Drug Rash With Eosinophilia and Systemic Symptoms
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cefepime
Possible Cefepime side effects in 47 year old female
Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-05-30
Patient: 47 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: Hepatomegaly, Respiratory Disorder, Respiratory Tract Haemorrhage, Candidiasis, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amphotericin B
Dosage: 30 mg/day, 6 hours of infusion
Indication: Candidiasis
Cefepime
Dosage: 2 g, every eight hours
Indication: Febrile Neutropenia
Cytarabine
Dosage: 370 mg/m2/day
Indication: Acute Promyelocytic Leukaemia
Fluconazole
Dosage: 200 mg/day
Administration route: Oral
Indication: Candidiasis
Metamizole
Dosage: 500 mg
Administration route: Oral
Indication: Febrile Neutropenia
Mitoxantrone
Dosage: 20 mg/m2/day
Indication: Acute Promyelocytic Leukaemia
Tretinoin
Dosage: 40 mg/m2/day continuously
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Other drugs received by patient: Meropenem; Methotrexate; Tretinoin
Possible Cefepime side effects in 45 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23
Patient: 45 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Confusional State, Dyskinesia, Hypotonia, Altered State of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cefepime
Dosage: 6 g, 1x/day
Indication: Cord Blood Transplant Therapy
Start date: 2011-12-30
End date: 2012-01-15
Cyclophosphamide
Dosage: 1905 mg, unk
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-05
End date: 2012-01-06
Fludarabine Phosphate
Dosage: 68 mg, unk
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-05
End date: 2012-01-08
Neoral
Dosage: unk
Start date: 2011-10-29
End date: 2012-01-15
Targocid
Dosage: 400 mg, 1x/day
Start date: 2011-12-27
End date: 2012-01-15
Thymoglobulin
Dosage: 476 mg, unk
Indication: Cord Blood Transplant Therapy
Start date: 2012-01-09
End date: 2012-01-10
Vfend
Dosage: 400 mg, 1x/day
Indication: Candidiasis
Start date: 2011-12-30
End date: 2012-01-15
Possible Cefepime side effects in 53 year old male
Reported by a pharmacist from United States on 2012-05-22
Patient: 53 year old male
Reactions: Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefepime
|